NPI: 1225146400 · LEVELLAND, TX 79336 · Ambulance · NPI assigned 08/28/2006
Authorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
| Authorized Official | ANDERSON, DONALD (ASSISTANT SECRETARY OF ENROLLMENTS) |
| NPI Enumeration Date | 08/28/2006 |
Other providers sharing the same authorized official: ANDERSON, DONALD
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 896 | $48K |
| 2021 | 8,300 | $348K |
| 2022 | 13,540 | $763K |
| 2023 | 12,432 | $714K |
| 2024 | 5,867 | $374K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 3,770 | 3,653 | $468K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 2,211 | 2,143 | $435K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 1,011 | 971 | $328K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2,931 | 2,789 | $187K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3,633 | 3,474 | $176K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 2,707 | 2,626 | $135K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 808 | 773 | $115K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2,371 | 1,206 | $60K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 124 | 119 | $50K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 148 | 139 | $42K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 768 | 742 | $28K |
| 36415 | Collection of venous blood by venipuncture | 5,229 | 4,654 | $27K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 303 | 288 | $27K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3,820 | 3,491 | $26K |
| 80053 | Comprehensive metabolic panel | 2,492 | 2,302 | $18K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 29 | 26 | $17K |
| 86780 | 714 | 676 | $14K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,202 | 1,135 | $13K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 381 | 362 | $8K |
| 83036 | Hemoglobin; glycosylated (A1C) | 661 | 645 | $7K |
| 84443 | Thyroid stimulating hormone (TSH) | 425 | 416 | $7K |
| 87807 | 277 | 264 | $6K | |
| 81003 | 1,802 | 1,258 | $6K | |
| 87150 | 110 | 110 | $6K | |
| 71045 | Radiologic examination, chest; single view | 79 | 74 | $5K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 47 | 45 | $4K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 70 | 69 | $3K |
| 86850 | 138 | 133 | $3K | |
| 83655 | 142 | 138 | $3K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 52 | 52 | $2K |
| 86762 | 79 | 78 | $2K | |
| 81001 | 707 | 644 | $2K | |
| 87486 | 29 | 26 | $1K | |
| 87581 | 29 | 26 | $1K | |
| 86735 | 62 | 62 | $1K | |
| 86765 | 62 | 62 | $1K | |
| 87340 | 82 | 80 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 46 | 45 | $1K |
| 84703 | 101 | 92 | $1K | |
| 84439 | 153 | 151 | $1K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 137 | 125 | $1K |
| 80050 | General health panel | 39 | 38 | $1K |
| 74018 | 16 | 14 | $1K | |
| 80061 | Lipid panel | 100 | 94 | $902.55 |
| 87081 | 222 | 205 | $695.51 | |
| 86901 | 138 | 133 | $621.13 | |
| 86900 | 138 | 133 | $621.13 | |
| 85018 | 163 | 154 | $596.14 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 12 | 12 | $528.76 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 12 | 12 | $365.60 |
| 87070 | 43 | 42 | $226.37 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 16 | 15 | $211.00 |
| 81000 | 48 | 38 | $206.20 | |
| 86580 | 16 | 13 | $192.08 | |
| 86592 | 15 | 15 | $121.42 | |
| 81025 | 14 | 12 | $73.39 | |
| 83880 | 14 | 12 | $31.90 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 87 | 72 | $0.01 |